These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8859405)

  • 1. In vitro release of new quinolones from biodegradable systems: a comparative study.
    Andreopoulos AG; Korakis T; Dounis E; Anastasiadis A; Tzivelekis P; Kanellakopoulou K
    J Biomater Appl; 1996 Apr; 10(4):338-47. PubMed ID: 8859405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of newer quinolones from biodegradable systems based on poly(lactic acid).
    Andreopoulos AG
    J Biomater Appl; 1995 Oct; 10(2):163-70. PubMed ID: 8618209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of polylactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study.
    Kanellakopoulou K; Kolia M; Anastassiadis A; Korakis T; Giamarellos-Bourboulis EJ; Andreopoulos A; Dounis E; Giamarellou H
    Antimicrob Agents Chemother; 1999 Mar; 43(3):714-6. PubMed ID: 10049299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
    Ramchandani M; Robinson D
    J Control Release; 1998 Jul; 54(2):167-75. PubMed ID: 9724903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of ofloxacin microspheres for the eradication of bone associated bacterial biofilm.
    Habib M; Onyilofor S; Ebube NK; Owusu-Ababio G
    J Microencapsul; 1999; 16(1):27-37. PubMed ID: 9972500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained drug release characteristics of biodegradable composite poly(d,l)lactic acid-poly(l)lactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):39-55. PubMed ID: 10676576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonstoichiometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and norfloxacin/ciprofloxacin.
    Amaro Martins VC; Goissis G
    Artif Organs; 2000 Mar; 24(3):224-30. PubMed ID: 10759646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal delivery of ciprofloxacin.
    Hainsworth DP; Conklin JD; Bierly JR; Ax D; Ashton P
    J Ocul Pharmacol Ther; 1996; 12(2):183-91. PubMed ID: 8773934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effect biodegradable ciprofloxacin loaded implantable matrices for osteomyelitis: controlled release and osteointegration.
    Hanafy AF; Ali HSM; El Achy SN; Habib EE
    Drug Dev Ind Pharm; 2018 Jun; 44(6):1023-1033. PubMed ID: 29484904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
    Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
    Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
    Cheow WS; Hadinoto K
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert.
    Mundada AS; Shrikhande BK
    Curr Eye Res; 2008 May; 33(5):469-75. PubMed ID: 18568884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
    Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H
    Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release systems based on poly(lactic acid). An in vitro and in vivo study.
    Andreopoulos AG; Hatzi EC; Doxastakis M
    J Mater Sci Mater Med; 2000 Jun; 11(6):393-7. PubMed ID: 15348021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiinfectious biomaterials. Ciprofloxacin containing polyurethanes as potential drug delivery systems to prevent foreign-body infections.
    Schierholz JM; Rump A; Pulverer G
    Arzneimittelforschung; 1997 Jan; 47(1):70-4. PubMed ID: 9037447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres.
    Martinez B; Lairion F; Pena MB; Di Rocco P; Nacucchio MC
    J Microencapsul; 1997; 14(2):155-61. PubMed ID: 9132467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infection.
    Chen L; Wang H; Wang J; Chen M; Shang L
    J Biomed Mater Res B Appl Biomater; 2007 Nov; 83(2):589-95. PubMed ID: 17410574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study of fibrin clot-ciprofloxacin complex: an in vitro and in vivo experimental investigation.
    Tsourvakas S; Hatzigrigoris P; Tsibinos A; Kanellakopoulou K; Giamarellou H; Dounis E
    Arch Orthop Trauma Surg; 1995; 114(5):295-7. PubMed ID: 7577224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.